SCHEMBL7874774

SCHEMBL7874774

Cc1cnc(NC(=O)[C@@H](N)C(C)(C)C)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 2/20 0.53
RAB9A P51151 10/20 0.50
SMN1; SMN2 Q16637 7/20 0.49
NPC1 O15118 7/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.47
PKM P14618 3/20 0.47
MAPT P10636 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
FDPS P14324 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44
CDK5 Q00535 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13156686 0.79 CCNE1 (0.68) FFAR2RAB9ASMN1; SMN2NPC1MEN1
SCHEMBL5875694 0.77 FFAR2 (0.48) FFAR2RAB9ASMN1; SMN2NPC1MEN1
SCHEMBL2880446 0.76 RAB9A (0.56) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL26818237 0.75 RAB9A (0.58) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL7868167 0.75 POLB (0.54) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL3794688 0.75 RAB9A (0.62) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL6056907 0.74 HSPA5 (0.57) FFAR2NPC1MEN1KMT2ALMNA
SCHEMBL4119851 0.74 HSPA5 (0.57) FFAR2NPC1MEN1KMT2ALMNA
SCHEMBL19449891 0.74 NPC1 (0.49) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL2175131 0.73 RAB9A (0.60) RAB9ASMN1; SMN2NPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed